Digital microscopic imaging company Optiscan (ASX: OIL) has gotten feedback from the US Food and Drug Administration (FDA) in relation to its Pre-Market Notification (510(k)) application for the InVivage product intended for oral tissue imaging. FDA’s regulatory clearance for the product requires that both the fluorescent contrast agent drug and the device used to visualise
Read MoreWould you call selling your intellectual property to your own company a boss move? For Managing Director, Prof Camile Farah, heck yes. Endomicroscopic imaging tech company Optiscan Imaging (ASX: OIL) has entered into a binding Terms Sheet with Managing Director, Prof Camile Farah, to acquire intellectual property in the form of clinical and histopathological datasets.
Read MoreWith increasing health awareness across China, medtech company Optiscan (ASX: OIL) is set to increase the exposure of their in vivo microscopic imaging camera which can be thread through the human body for use in cancer detection and surgery. The increased exposure will come through a freshly inked distribution partnership with biotech company Sinsi Technology
Read MoreThe content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.